|
⚲
|
| Keyboard |
| Joshua Funder | |
|---|---|
| Firm | |
| Address | Gbs Venture Partners Limited Level 5, 71 Collins Street Melbourne Vic, C3 3000 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Spinifex Pharmaceuticals Inc | 021-216941 | Director | 6.2 M of 16.0 M |
||
| Celladon Corp | 021-205300 | Director | 1.1 M of 2.4 M |
||
| Pathway Therapeutics Inc | 021-192819 | Director | 0.4 M of 0.8 M |
||
| Pathway Therapeutics Inc | 021-187687 | Director | 0.2 M of 0.4 M |
||
| Euthymics Bioscience Inc | 021-187522 | Director | 3.0 M of 6.0 M |
||
| Neurovance Inc | 021-185561 | Director | 26.5 M of 26.5 M |
||
| EBI Life Sciences Inc | 021-175100 | Director | 0.0 M of 0.0 M |
||
| Neurovance Inc | 021-175102 | Director | 0.5 M of 0.5 M |
||
| Celladon Corp | 021-172955 | Director | 19.5 M of 64.5 M |
||
| Pathway Therapeutics Inc | 021-160907 | Director | 7.5 M of 9.7 M |
||
| NUON Therapeutics Inc | 021-146233 | Director | 10.0 M of 10.0 M |
||
| Euthymics Bioscience Inc | 021-145679 | Director | 28.0 M of 28.0 M |
||
| NUON Therapeutics Inc | 021-117069 | Director | 6.1 M of 6.1 M |
||